PL375233A1 - Leki inhalacyjne zawierające nowy lek antycholinoesterazowy w połączeniu z kortykosteroidami i lekami betamimetycznymi - Google Patents

Leki inhalacyjne zawierające nowy lek antycholinoesterazowy w połączeniu z kortykosteroidami i lekami betamimetycznymi

Info

Publication number
PL375233A1
PL375233A1 PL03375233A PL37523303A PL375233A1 PL 375233 A1 PL375233 A1 PL 375233A1 PL 03375233 A PL03375233 A PL 03375233A PL 37523303 A PL37523303 A PL 37523303A PL 375233 A1 PL375233 A1 PL 375233A1
Authority
PL
Poland
Prior art keywords
corticosteroids
conjunction
anticholinergic
beta
medicaments containing
Prior art date
Application number
PL03375233A
Other languages
English (en)
Other versions
PL212070B1 (pl
Inventor
Michel Pairet
Christopher John Montague Meade
Michael Paul Pieper
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of PL375233A1 publication Critical patent/PL375233A1/pl
Publication of PL212070B1 publication Critical patent/PL212070B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL375233A 2002-08-17 2003-07-25 Kompozycje farmaceutyczne do inhalacji zawierające lek antycholinergiczny i kortykosteroid i ich zastosowanie PL212070B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10237739A DE10237739A1 (de) 2002-08-17 2002-08-17 Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika

Publications (2)

Publication Number Publication Date
PL375233A1 true PL375233A1 (pl) 2005-11-28
PL212070B1 PL212070B1 (pl) 2012-08-31

Family

ID=30775387

Family Applications (1)

Application Number Title Priority Date Filing Date
PL375233A PL212070B1 (pl) 2002-08-17 2003-07-25 Kompozycje farmaceutyczne do inhalacji zawierające lek antycholinergiczny i kortykosteroid i ich zastosowanie

Country Status (21)

Country Link
EP (2) EP1530471B1 (pl)
JP (1) JP2006501253A (pl)
KR (1) KR101083977B1 (pl)
CN (1) CN1688308A (pl)
AT (1) ATE366574T1 (pl)
AU (1) AU2003255289B2 (pl)
BR (1) BR0313526A (pl)
CA (1) CA2495454C (pl)
CO (1) CO5540380A2 (pl)
CY (1) CY1107742T1 (pl)
DE (2) DE10237739A1 (pl)
DK (1) DK1530471T3 (pl)
ES (1) ES2290549T3 (pl)
IL (1) IL166891A (pl)
MX (1) MXPA05001823A (pl)
NZ (1) NZ538834A (pl)
PL (1) PL212070B1 (pl)
PT (1) PT1530471E (pl)
RU (1) RU2332217C2 (pl)
WO (1) WO2004022058A1 (pl)
ZA (1) ZA200500019B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2067784A3 (en) 2000-08-05 2012-08-22 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
WO2002088167A1 (en) 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
DE102004024453A1 (de) * 2004-05-14 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen
US20060034776A1 (en) * 2004-08-10 2006-02-16 Boehringer Ingelheim International Gmbh Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics
DE102004056579A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
DE102004056578A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid
SG159550A1 (en) 2005-02-25 2010-03-30 Chiesi Farma Spa Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
WO2006105401A2 (en) * 2005-03-30 2006-10-05 Schering Corporation Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
RU2369411C2 (ru) * 2005-04-21 2009-10-10 Бёрингер Ингельхайм Интернациональ Гмбх Порошковый ингалятор
EP1879571A1 (de) * 2005-04-23 2008-01-23 Boehringer Ingelheim International GmbH Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
RU2431501C2 (ru) * 2005-07-14 2011-10-20 Липотера, Инк. Липолитические составы с пролонгированным высвобождением для локального лечения отложения жировых тканей
KR101360803B1 (ko) 2005-08-15 2014-02-11 베링거 인겔하임 인터내셔날 게엠베하 베타모방제의 제조방법
JP2011500731A (ja) * 2007-10-25 2011-01-06 メルク フロスト カナダ リミテツド 併用療法
AU2010253770B9 (en) 2009-05-29 2015-02-12 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
RU2479304C1 (ru) * 2012-05-29 2013-04-20 Шолекс Девелопмент Гмбх, Стабильный раствор фенотерола гидробромида
RU2504382C1 (ru) * 2012-06-13 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
NZ706573A (en) 2012-12-21 2019-11-29 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
DK3473255T3 (da) 2012-12-21 2022-04-04 Boehringer Ingelheim Vetmedica Gmbh Farmaceutisk formulering omfattende ciclesonid
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
DK3157522T3 (da) * 2014-06-18 2019-12-09 Boehringer Ingelheim Vetmedica Gmbh Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003935D0 (en) * 2000-02-08 2000-04-12 King S College London Formulation for dry powder inhaler
JP5392880B2 (ja) * 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika

Also Published As

Publication number Publication date
RU2005107475A (ru) 2006-04-10
JP2006501253A (ja) 2006-01-12
EP1530471A1 (de) 2005-05-18
AU2003255289B2 (en) 2009-08-20
DK1530471T3 (da) 2007-10-22
AU2003255289A1 (en) 2004-03-29
KR101083977B1 (ko) 2011-11-22
MXPA05001823A (es) 2005-04-19
CA2495454A1 (en) 2004-03-18
RU2332217C2 (ru) 2008-08-27
EP1530471B1 (de) 2007-07-11
CN1688308A (zh) 2005-10-26
IL166891A (en) 2010-04-15
EP1785136A3 (de) 2009-04-22
WO2004022058A1 (de) 2004-03-18
BR0313526A (pt) 2005-06-28
EP1785136A2 (de) 2007-05-16
ZA200500019B (en) 2006-07-26
NZ538834A (en) 2007-10-26
KR20050051644A (ko) 2005-06-01
CA2495454C (en) 2011-09-06
DE50307659D1 (de) 2007-08-23
PL212070B1 (pl) 2012-08-31
CY1107742T1 (el) 2013-04-18
DE10237739A1 (de) 2004-02-26
PT1530471E (pt) 2007-07-26
ATE366574T1 (de) 2007-08-15
CO5540380A2 (es) 2005-07-29
ES2290549T3 (es) 2008-02-16

Similar Documents

Publication Publication Date Title
EP1785136A3 (de) Inhalative Arzneimittel enthaltend ein Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
CY1108776T1 (el) Σκευασμα αερολυματος για εισπνοη που περιεχει αντιχολινεργικο
RU2005121162A (ru) Производные хинуклидина, фармацевтическая композиция и способ лечения респираторных, урологических или желудочно-кишечных заболеваний
ES2257757T3 (es) Carboxilato de terfenadina y el tratamiento de trastornos alergicos.
TW200516078A (en) Aerosol formulation for inhalation comprising an anticholinergic
JP2002506047A (ja) Ｎｍｄａレセプター拮抗薬及び麻酔性鎮痛薬を含む鎮痛組成物。
NZ524396A (en) Fentanyl composition for nasal administration comprising water as a solvent
RU2013155903A (ru) Композиции, способы и устройства для респираторной доставки двух или более активных средств
MY137045A (en) Medicaments comprising steroids and a novel anticholinergic
ZA200409676B (en) Novel drug compositions based on novel anticholinergics and inhibitors of EGFR-kinase
IL43820A (en) Pharmacological preparations for the treatment of deformed disabled, containing symptomatic aminophytic bronchodilators
PT1526848E (pt) Antagonistas dos receptores de opióides em sistemas transdérmicos contendo buprenorfina
AR059126A1 (es) Uso de sales de tiotropio en el tratamiento del asma persistente moderada
JP2007500194A (ja) 呼吸器疾患治療用の新規な長時間作用型医薬の組合せ
TW200744606A (en) Use of tiotropium salts in the treatment of severe persistent asthma
Vincken Clinical efficacy and safety of the combination of ipratropium bromide and fenoterol inhaled via the Respimat© Soft Mist™ inhaler for relief of airflow obstruction
Slattery et al. Newer methods of delivery of opiates for relief of pain
TH78671A (th) สูตรผสมแอโรซอลสำหรับการสูดดม ซึ่งประกอบรวมด้วยแอนติโคลิเนอร์จิก
AU2003208703A1 (en) Difurylglycolic acid tropenol esters used as anticholinesterase drugs
Baker et al. Normal pharmacokinetics of doxapramin in a patient with renal failure and hypothyroidism
Østerlind et al. Vindesine in the Treatment of Lung Cancer–
CA3157364A1 (en) Prophylaxis and reversal of stimulant and opioid/opiate overdose and/or toxic exposure
Paudel et al. Development of Opioid Transdermal Delivery Systems
JP2008526917A5 (pl)
BATES BCC Responds to Hedgehog Signal Suppression

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20130725